NCT00134342View on ClinicalTrials.gov

Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations

CompletedOBSERVATIONAL
Enrollment

203

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Tuberculosis
Interventions
OTHER

T-SPOT TB ELISPOT test

ELISPOT test for detecting T cell responses to tuberculosis antigens.

Trial Locations (2)

M5G 1X5

Mount Sinai Hospital, Toronto

M5G 2C4

University Health Network, Toronto

Sponsors

Collaborators (1)

Oxford Immunotec
All Listed Sponsors
collaborator

Oxford Immunotec

INDUSTRY

lead

University Health Network, Toronto

OTHER